Our name speaks for us. Did you know that the Chinese character “ren” means “people” and “humanity”?
RenBio was founded on the principle that the remarkable medical benefits of antibody therapeutics should be a right and be available to everyone who needs it.
Our mission is clear: we want to advance first-in-class and best-in-class DNA therapeutic technologies to humans.
We aim to enhance the field of antibodies and therapeutic proteins. We believe this is essential for creating a better world by reducing the impact of diseases worldwide.
Our goals are achievable as we strive for them daily. Nonetheless, they remain audacious. Firstly, we want to deliver antiviral antibodies to prevent the spread of infectious diseases. No less important, the improvement of the dosing regimen and effectiveness of therapeutic proteins is also on our list.
RenBio’s Make Your Own Technology (MYO) delivers therapeutic “bioblueprints” through modified injections.
Muscle cells decode these blueprints to create an antibody factory that will produce disease-fighting treatments within the patient’s body.
We’re discussing DNA molecules here.
Antibodies and proteins therapeutics have significant potential in improving human health. However, challenges in administration, efficacy, duration, and cost limit their use. We have reimagined how we can help in this field, producing and delivering antibody and protein therapeutics to overcome these obstacles.
Our delivery platform uses the body’s ability to create specific antibodies or therapeutic proteins by giving it the right genetic instructions. These instructions, encoded in DNA, are biological blueprints, or “bioblueprints”.
RenBio was co-founded by Drs. David Ho and Yaoxing Huang, visionary scientists and part of the Aaron Diamond AIDS Research Center in New York City.
Since 2016, our team has grown quickly and now includes experts in biology and engineering, with knowledge in various areas.
We use our knowledge and skills to create a technology. This technology can make antibodies and proteins.
We use these antibodies and proteins to prevent and treat various diseases. Our dedicated team is always working on the next-generation medicines.